MLS: NYCFC M Keaton Parks recovering from leg surgery

Date:

Share post:


New York City FC midfielder Keaton Parks underwent another surgery to address blood flow issues in his right leg.

The team said Wednesday that there is no recovery timeline yet for Parks, who had similar procedures in 2021 and 2022.

“Keaton’s health and well being is our priority. The decision to have surgery to address this issue is best for Keaton’s health both now and long-term,” NYCFC sporting director David Lee said. “… Keaton has been an important player for us this season, and it’s disappointing to lose a player of his caliber in the middle of the campaign.

“Our medical team has engaged with several world-leading experts in vascular health, ensuring that Keaton is receiving the best medical advice in addressing the current issues and moving forward.”

Parks, 27, has recorded one goal and two assists in 14 MLS matches (10 starts) this season, his seventh with NYCFC. He has 15 goals and six assists in 172 career matches (144 starts) and helped the club win the MLS Cup in 2021 and the Campeones Cup in 2022.

Parks is under contract with New York City through 2026 with team options for 2027 and 2028.

–Field Level Media

spot_img

Related articles

NWSL: Reign sign M Sofia Cedeno, 19, through 2028 season

The Seattle Reign signed midfielder Sofia Cedeno through the 2028 season, the NWSL club announced Monday. The 19-year-old Panama...

MLS: Lionel Messi: ‘This is the moment I had been waiting for’

Lionel Messi checked a few more boxes on his already impressive resume Saturday. Messi notched a pair of assists...

FIFA: What cities got the best slate of games? Analyzing the 2026 World Cup schedule

FIFA revealed the full schedule, including venues and kickoff times, for the 2026 World Cup on Saturday, one...

MLS: Inter Miami takes down Whitecaps to win first MLS Cup

Lionel Messi assisted Rodrigo de Paul in the 71st minute and Tadeo Allende in second-half stoppage time as...

FREE

Get the most important breaking news and analyses for Free.

Thank you for subscribing

Something went wrong.